According to a new study published by the journal BioMed Research International, tetrahydrocannabinol (THC) may be “a potential new target for the treatment of diabetes-induced cardiovascular disease.” “The aim of this study was to determine if chronic, low-dose administration of a nonspecific cannabinoid receptor agonist could provide cardioprotective effects in a model of type I diabetes mellitus”, states …
